Home / Health / Meningitis B: Families Demand Action for Young Adults
Meningitis B: Families Demand Action for Young Adults
2 Dec
Summary
- Advocates push for MenB vaccine availability for young adults on NHS.
- One in four Meningitis survivors face lifelong health complications.
- Meningitis B can be fatal within 24 hours if not treated promptly.
Grief has fueled a powerful advocacy for enhanced Meningitis B awareness and vaccine accessibility. Following a young adult's death from the disease, her family is determined to prevent further tragedies, emphasizing that her passing should not be in vain. They champion the provision of the MenB vaccine on the NHS for young adults, a group currently not routinely covered.
This push comes amid stark statistics: one in four Meningitis survivors endure permanent health problems, while the illness itself can prove fatal within a mere 24 hours. Health organizations and student unions are amplifying calls for preventative measures, stressing that early detection and vaccination are crucial. Universities are also urged to consider offering the vaccine to their students, removing cost barriers to life-saving immunizations.
The current vaccination policy, guided by the Joint Committee on Vaccination and Immunisation (JCVI), primarily targets infants. Advocates argue this policy leaves a critical gap, potentially exposing young adults, particularly those in shared living environments like universities, to preventable risks. The campaign underscores that investing in preventative healthcare, like widespread MenB vaccination, is essential for safeguarding public health and keeping families intact.
